Peginterferon alpha-2b（Vir Biotechnology）

N/A

Report date: 2024/06/18 20:00:07

Base Information

Drug NamePeginterferon alpha-2b（Vir Biotechnology）
Drug Alias NamePEG-IFNα（Vir Biotechnology）
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeTaiwanThailand +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesVir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesVir Biotechnology IncBrii Biosciences (Shanghai) Co LtdBrii Biosciences (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A